PubRank

J L Tayot

Author PubWeight™ 14.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside. Eur J Biochem 1981 1.89
2 [Direct agglutination test for toxoplasma. Role of immunoglobulins 19S and 7S. Preliminary notes]. Ann Biol Clin (Paris) 1973 1.20
3 Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr 1996 1.09
4 Separation of gangliosides on a new type of anion-exchange resin. Biochim Biophys Acta 1980 1.08
5 Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res 1997 1.04
6 Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat. Am J Physiol 1996 0.89
7 Stable isotope tracer and gas-chromatography combustion isotope ratio mass spectrometry to study the in vivo compartmental metabolism of docosahexaenoic acid. Anal Biochem 1994 0.87
8 Fibroblast behavior on gels of type I, III, and IV human placental collagens. Exp Cell Res 1990 0.83
9 Growth suppression of transformed cells by a human placental extract not related to transforming growth factor beta. J Cancer Res Clin Oncol 1991 0.82
10 Interaction of solid-phase gangliosides with tetanus toxin and toxoid. Toxicon 1985 0.78
11 Affinity chromatographic purification and characterization of two iodinated tetanus toxin fractions exhibiting different binding properties. Toxicon 1984 0.78
12 Isolation of cholera toxin by affinity chromatography on porous silica beads with covalently coupled ganglioside GM1. Adv Exp Med Biol 1980 0.77
13 Large scale use of Spherosil ion exchangers in plasma fractionation. Dev Biol Stand 1987 0.77
14 Biocompatibility of human collagen type IV intracorneal implants. Cornea 1989 0.77
15 Phospholipid molecular species from human placenta lipids. Lipids 1993 0.76
16 [Human collagen IV lenses and epikeratoplasy in monkeys. Study of epithelial cicatrization]. Ophtalmologie 1991 0.75
17 [Human placental tissue: a source of natural hematopoietic regulators]. C R Acad Sci III 1987 0.75
18 [Use of human placental type IV collagen in tympanoplasty. Results of initial animal experimentation]. Ann Otolaryngol Chir Cervicofac 1990 0.75
19 [Application of density gradient ultracentrifugation in the analysis of immunoglobulins]. J Biol Stand 1974 0.75
20 Characterization of a human placental factor which inhibits specific binding of phorbol esters to cultured cells. Carcinogenesis 1984 0.75
21 [Epikeratoplasty without sutures using collagen IV lens in monkeys: description of the surgical technic]. J Fr Ophtalmol 1990 0.75
22 Safety of placental blood derivatives. Lancet 1994 0.75
23 Hemoglobin solutions coupled with polyethylene glycol 1900: preparation, purification, quality control and pharmacological trials by hemorrhagic shock. Int J Artif Organs 1988 0.75
24 [The passive hemagglutination test in the evaluation of antitetanus immunity]. Dev Biol Stand 1978 0.75
25 Modulation of cellular phorbol ester binding and/or protein kinase C activity by human placental fractions. Biochim Biophys Acta 1988 0.75
26 Quality of the humoral immunity conferred by RA 27-3 rubella vaccine. Biomedicine 1973 0.75
27 [Viscous human collagen IV. Physical properties and experimental tolerance]. Ophtalmologie 1990 0.75
28 [Physico-chemical properties of purified Australia antigen]. Prog Immunobiol Stand 1971 0.75
29 Purification of large quantities of Australia antigen by density gradient centrifugation. Am J Dis Child 1972 0.75
30 Isolation and characterization of two different molecular forms of basic fibroblast growth factor extracted from human placental tissue. J Chromatogr 1991 0.75
31 Towards large-scale purification of natural CSF-1 from human placenta tissue extracts. Biotechnol Appl Biochem 1990 0.75
32 In vivo compartmental metabolism of 13C-docosahexaenoic acid, studied by gas chromatography-combustion isotope ratio mass spectrometry. Lipids 1996 0.75
33 A phorbol ester-binding inhibitory factor from human placenta. Partial purification, characterization and biological effects. IARC Sci Publ 1984 0.75
34 [European standards with regard to the control of human immunoglobulins by ultracentrifugation]. Dev Biol Stand 1974 0.75
35 [Use of human collagen (type IV) in refractive corneal surgery. Experimental study]. Ophtalmologie 1988 0.75
36 [Experimental cholera in monkeys]. Bull Soc Pathol Exot Filiales 1979 0.75